Taibang Biological Group

Taibang Biological Group is a prominent biopharmaceutical company in China specializing in the development and manufacturing of human plasma-based products. Established in 2002, the company operates across the entire plasma product value chain, encompassing plasma collection, research and development, production, and commercialization. Taibang's diverse product portfolio includes human albumin, immunoglobulin for intravenous injection, and coagulation factor products, which are essential therapies for medical emergencies and the treatment of severe diseases and immune deficiencies. The company is committed to advancing its technology and expanding its offerings, continuously working on new pipeline products to enhance patient care and improve quality of life. Through its robust R&D capabilities, Taibang aims to meet the evolving needs of healthcare providers and patients alike.